Cargando…

COX-2 Silencing in Canine Malignant Melanoma Inhibits Malignant Behaviour

Metastatic melanoma is a very aggressive form of cancer in both humans and dogs. Dogs primarily develop oral melanoma of mucosal origin. Although oral melanoma in humans is rare, both diseases are highly aggressive with frequent metastases. This disease represents a “One Health” opportunity to impro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silveira, Tatiany L., Pang, Lisa Y., Di Domenico, Alexandra, Veloso, Emerson S., Silva, Istéfani L. D., Puerto, Helen L. Del, Ferreria, Enio, Argyle, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427276/ https://www.ncbi.nlm.nih.gov/pubmed/34513965 http://dx.doi.org/10.3389/fvets.2021.633170

Ejemplares similares

Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas
por: Veloso, Emerson Soares, et al.
Publicado: (2020)

Clinical utility of liquid biopsy in canine oral malignant melanoma using cell-free DNA
por: Tagawa, Michihito, et al.
Publicado: (2023)

Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up
por: Saellstrom, Sara, et al.
Publicado: (2021)

New Insights Into the Role of Qa-2 and HLA-G Non-classical MHC-I Complexes in Malignancy
por: da Silva, Istéfani L., et al.
Publicado: (2018)

COX-2 expression in mammary invasive micropapillary carcinoma is associated with prognostic factors and acts as a potential therapeutic target in comparative oncology
por: Vieira, Thaynan Cunha, et al.
Publicado: (2022)

Quantitative Expression of TYR, CD34, and CALD1 Discriminates Between Canine Oral Malignant Melanomas and Soft Tissue Sarcomas
por: Tsoi, Mayra F., et al.
Publicado: (2021)

Current Status of Canine Melanoma Diagnosis and Therapy: Report From a Colloquium on Canine Melanoma Organized by ABROVET (Brazilian Association of Veterinary Oncology)
por: Fonseca-Alves, Carlos Eduardo, et al.
Publicado: (2021)

Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines
por: Gray, Mark, et al.
Publicado: (2020)

Corrigendum: Comparative Analysis of the Development of Acquired Radioresistance in Canine and Human Mammary Cancer Cell Lines
por: Gray, Mark, et al.
Publicado: (2021)

PDPN Is Expressed in Various Types of Canine Tumors and Its Silencing Induces Apoptosis and Cell Cycle Arrest in Canine Malignant Melanoma
por: Shinada, Masahiro, et al.
Publicado: (2020)

T Cell Immune Profiles of Blood and Tumor in Dogs Diagnosed With Malignant Melanoma
por: Sparger, Ellen E., et al.
Publicado: (2021)

Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells
por: da Silva, Istéfani L., et al.
Publicado: (2017)

Transcriptomic analysis by RNA sequencing characterises malignant progression of canine insulinoma from normal tissue to metastatic disease
por: Capodanno, Y., et al.
Publicado: (2020)

Tools and techniques for classifying behaviours in canine epilepsy
por: Folkard, Emily, et al.
Publicado: (2023)

Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation
por: Pang, Lisa Y., et al.
Publicado: (2014)

Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research
por: Tarone, Lidia, et al.
Publicado: (2022)

Identification of dysregulated microRNAs in canine malignant melanoma
por: Ushio, Norio, et al.
Publicado: (2019)

A Review of Immunotherapeutic Strategies in Canine Malignant Melanoma
por: Almela, Ramón M., et al.
Publicado: (2019)

The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro
por: Pang, Lisa Y, et al.
Publicado: (2014)

A pilot study for a non-invasive system for detection of malignancy in canine subcutaneous and cutaneous masses using machine learning
por: Dank, Gillian, et al.
Publicado: (2023)

Antineoplastic effects of sodium dichloroacetate and omeprazole, alone or in combination, on canine oral mucosal melanoma cells
por: Toledo, Gabriela F., et al.
Publicado: (2023)

Angiotropic metastatic malignant melanoma in a canine mammary gland
por: Yang, Hai Jie, et al.
Publicado: (2011)

Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression
por: Bowlt Blacklock, K. L., et al.
Publicado: (2019)

Molecular and Immunohistochemical Expression of LTA4H and FXR1 in Canine Oral Melanoma
por: Nordio, Laura, et al.
Publicado: (2021)

Tumor-Associated Macrophages in Canine Oral and Cutaneous Melanomas and Melanocytomas: Phenotypic and Prognostic Assessment
por: Porcellato, Ilaria, et al.
Publicado: (2022)

Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies
por: Stevenson, Valentina B., et al.
Publicado: (2023)

Training and validation of a novel non-invasive imaging system for ruling out malignancy in canine subcutaneous and cutaneous masses using machine learning in 664 masses
por: Dank, Gillian, et al.
Publicado: (2023)

Cytoglobin Silencing Promotes Melanoma Malignancy but Sensitizes for Ferroptosis and Pyroptosis Therapy Response
por: De Backer, Joey, et al.
Publicado: (2022)

Canine Brucellosis: An Update
por: Santos, Renato L., et al.
Publicado: (2021)

Electrochemotherapy in Treatment of Canine Oral Malignant Melanoma and Factors Influencing Treatment Outcome
por: Tellado, Matías Nicolás, et al.
Publicado: (2020)

Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma
por: Koo, Karen, et al.
Publicado: (2023)

Editorial: Canine melanoma in comparative oncology: Translate research advances to develop new diagnostic and therapeutic options
por: Bongiovanni, Laura, et al.
Publicado: (2023)

MALIGNANT MELANOMA – CUTANEOUS METASTASES
por: Padmavathy, L, et al.
Publicado: (2008)

The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
por: Jessen, Christina, et al.
Publicado: (2020)

Malignant melanoma
Publicado: (1998)

Malignant Melanoma
por: Ortega Candil, Aída, et al.
Publicado: (2012)

Malignant Melanoma
por: Perera, Eshini, et al.
Publicado: (2013)

Better Lives for Dogs: Incorporating Human Behaviour Change Into a Theory of Change to Improve Canine Welfare Worldwide
por: Reed, Karen, et al.
Publicado: (2018)

Pilot Study: Assessing the Expression of Serum Lactate Dehydrogenase and Peripheral Leukocyte Ratios in Canine Oral Malignant Melanoma
por: Murray, Ben, et al.
Publicado: (2022)

Oral contraceptives and malignant melanoma.
por: Hannaford, P. C., et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_im615o7lq68ndehvtuifn9h4or